中华放射肿瘤学杂志
Friday, Apr. 11, 2025   Home | Journal | Editorial | Instruction | Subscription | Advertisement | Academic | Index-in | Contact Us | Chinese
Chinese Journal of Radiation Oncology  2021, Vol. 30 Issue (12): 1286-1291    DOI: 10.3760/cma.j.cn113030-20201010-00494
Physics·Technique·Biology Current Issue| Next Issue| Archive| Adv Search [an error occurred while processing this directive] | [an error occurred while processing this directive]
Application of independent dose verification of volumetric modulated arc therapy based on Monte Carlo
Cui Tiantian, Li Bing, Liu Ru, Ding Danhong, Li Dingjie, Lou Zhaoyang, Ge Hong
Department of Radiation Oncology, Affiliated Cancer Hospital of Zhengzhou University/Henan Cancer Hospital, Zhengzhou 450008, China
Download: PDF (0 KB)   HTML (1 KB) 
Export: BibTeX | EndNote (RIS)      Supporting Info
Abstract  Objective To develop a verification platform based on Monte Carlo (MC) for independent dose verification of volumetric modulated arc therapy (VMAT) plans. Methods The head model including collimator of Varian TrueBeam linear accelerator was constructed by using EGSnrc/BEAMnrc, and the independent dose verification platform for the patients’ VMAT plans was built based on the head model and an in-house code. The percent depth dose (PDD) curves and off-axis ratios for different field sizes, the dose distribution of two irregular fields and three VMAT plans of the head and neck, chest, and pelvis were simulated using the platform. The simulated results of the PDD curves and the off-axis ratios of different field sizes were compared with the blue water measurement results. The difference between the irregular fields and the actual ArcCHECK measurements was also investigated. Besides, the differences among the MC simulated dose, TPS calculated dose and the ArcCHECK measured dose were analyzed by several methods, such as γ analysis and dose-volume histogram to verify whether the platform could be independently employed for dose verification. Results The MC simulated results of PDD curves and off-axis ratios from 4cm×4cm to 40cm×40cm were in good agreement with the measured results. And the γ passing rates between the MC simulation and the ArcCHECK measurement for the irregular fields were above 98.1% and 99.1% for 3%/2 mm and 3%/3 mm, respectively. For VMAT plans of three patients, the γ results between the MC simulated dose and ArcCHECK measured dose were better than 93.8% and 95.9% under the criteria of 3%/2 mm and 3%/3 mm respectively. At the same time, the γ passing rates of nasopharyngeal, lung, and rectal cancers were 95.2%, 98.6% and 98.9% based on 3D γ analysis using TPS calculated dose and MC simulated dose under the criteria of 3%/3 mm;the passing rates of these three were 90.3%, 95.1% and 96.7% for 3%/2 mm, respectively. Conclusions The simulation results of the MC-based verification platform developed in this study show a good agreement with the actual measurement results, and the simulation results are closer to the real dose distribution using the patients’ data. The preliminary results demonstrate that the platform can be used for accurate independent dose verification of VMAT plans.
Service
E-mail this article
Add to my bookshelf
Add to citation manager
E-mail Alert
RSS
Articles by authors
Cui Tiantian
Li Bing
Liu Ru
Ding Danhong
Li Dingjie
Lou Zhaoyang
Ge Hong
Key wordsVolumetric modulated arc therapy      Monte Carlo      Independent dose verification     
Received: 10 October 2020     
Corresponding Authors: Ge Hong, Email:gehong666@126.com   
Cite this article:   
Cui Tiantian,Li Bing,Liu Ru et al. Application of independent dose verification of volumetric modulated arc therapy based on Monte Carlo[J]. Chinese Journal of Radiation Oncology, 2021, 30(12): 1286-1291.
Cui Tiantian,Li Bing,Liu Ru et al. Application of independent dose verification of volumetric modulated arc therapy based on Monte Carlo[J]. Chinese Journal of Radiation Oncology, 2021, 30(12): 1286-1291.
URL:  
http://journal12.magtechjournal.com/Jweb_fszlx/EN/10.3760/cma.j.cn113030-20201010-00494     OR     http://journal12.magtechjournal.com/Jweb_fszlx/EN/Y2021/V30/I12/1286
  Copyright © 2010 Editorial By Chinese Journal of Radiation Oncology
Support by Beijing Magtech Co.ltd  support@magtech.com.cn